LLY
53
6
RF
67
-2
GRMN
67
-3
C
62
-3
KSS
26
-15
AMT
45
2
DUK
64
7
AMZN
59
3
JWN
59
2
GME
70
2
HSIC
60
-2
NWL
54
-3
BXP
60
5
IRM
52
2
MU
36
-6
DLTR
40
-2
URBN
50
-2
NWSA
63
-4
AES
41
-2
TEL
66
-3
LLY
53
6
RF
67
-2
GRMN
67
-3
C
62
-3
KSS
26
-15
AMT
45
2
DUK
64
7
AMZN
59
3
JWN
59
2
GME
70
2
HSIC
60
-2
NWL
54
-3
BXP
60
5
IRM
52
2
MU
36
-6
DLTR
40
-2
URBN
50
-2
NWSA
63
-4
AES
41
-2
TEL
66
-3
Financhill
Back

ArrowMark Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
49

BANX
ArrowMark Financial

Last Price:
20.61
Seasonality Move:
1.35%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
134.35
Seasonality Move:
14.88%
Sell
49
ArrowMark Financial (BANX) is a Sell

Is ArrowMark Financial a Buy, Sell or Hold?

  • The current ArrowMark Financial [BANX] share price is $20.74. The Score for BANX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BANX Stock Price Chart

What is ArrowMark Financial's stock price today?

  • The ArrowMark Financial share price today is $20.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BANX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 52.8 Buy
Chaikin Money Flow: -3085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.35 - 20.89) Buy
Bollinger Bands (100): (19.48 - 20.78) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

BANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.64 Buy
20-day SMA: 20.69 Buy
50-day SMA: 20.59 Buy
200-day SMA: 19.32 Buy
8-day EMA: 20.71 Buy
20-day EMA: 20.64 Buy
50-day EMA: 20.48 Buy
200-day EMA: 19.5 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ArrowMark Financial Earnings Growth & BANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ArrowMark Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):